Senate To Consider FDA User Fee Bill Amendments
Despite early fears of a filibuster, the U.S. Senate agreed Monday to move forward with the U.S. Food and Drug Administration user fee bill and will begin considering amendments on Tuesday,...To view the full article, register now.
Already a subscriber? Click here to view full article